right model. right insight.
Breaking News: InVivo Biosystems Secures New Investment to Accelerate CRISPR & MedTech Innovation
Appoints Commercialization Leader C. Palani Palaniappan, Ph.D. as Executive Board ChairmanRead the Press Release. >>
About InVivo Biosystems
Number of Employees
Number of PhDs
Average Years of Experience in Genetics
Number of Preclinical Models Created
Bridge the data gap between cell culture and rodent models. Rapidly conduct preclinical studies to de-risk your clinical trial.
An expert in CRISPR genome editing for creating custom genome edited zebrafish and C. elegans, our CRISPR genome editing platform enables preclinical studies and drug discovery by providing insights you need to derisk your clinical trial or decide the next phase of product devleopment.
Vitality & Antioxidant Study Report – an example of a client project report.
Download our sample data report to see an example of the dataset you would receive if you partnered with us.
Our newest white paper focus on the gut microbiome and discusses the questions: What is the microbiome? How does it help or hinder health? And, what does recent research indicate?
Dr. Marius Galyan (CEO and Founder at Galyan Bio, Inc.) shares his experience in working with InVivo Biosystems and how the Longevity Platform delivered the results he needed to accelerate his research.
READY TO GET STARTED?
Ready to connect with us to learn more about working with our company or our technology?
Submit your inquiry below & we will get back to you soon.